Company Kalytera Therapeutics Inc Toronto S.E.
Equities
CA48349P1036
Biotechnology & Medical Research
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,786,585 | 37,687,937 ( 99.74 %) | 0 | 99.74 % |
Company contact information
Claritas Pharmaceuticals, Inc.
4040 Civic Center Drive Suite 200
94903, San Rafael
+
http://www.claritaspharma.comSector
1st Jan change | Capi. | |
---|---|---|
+25.83% | 47.96B | |
+46.34% | 41.47B | |
+0.69% | 42.45B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |